Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2014 084 929.6 |
96 | EP file number | EAKZ | 14 71 5274.8 |
86 | WO file number | WAKZ | PCT/EP2014/056655 |
97 | EP publication number | EPN | 2981255 |
87 | WO publication number | WPN | 2014161918 |
54 | Designation/title | TI | THERAPEUTISCHE VERWENDUNGEN VON EMPAGLIFLOZIN |
51 | IPC main class | ICM (ICMV) | A61K 31/155 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/522 (2006.01), A61K 31/7048 (2006.01), A61P 9/10 (2006.01), A61P 3/10 (2006.01), A61K 45/06 (2006.01) |
22 | DE application date | DAT | Apr 3, 2014 |
96 | EP application date | EAT | Apr 3, 2014 |
86 | WO application date | WAT | Apr 3, 2014 |
43 | Date of first publication | OT | Oct 9, 2014 |
| Date of publication of grant | PET | Sep 14, 2022 |
71/73 | Applicant/owner | INH | Boehringer Ingelheim International GmbH, 55218 Ingelheim, DE |
72 | Inventor | IN | BROEDL, Uli Christian, 55216 Ingelheim Am Rhein, DE; CHERNEY, David, Burlington, Ontario L7L 5H4, CA; DAIBER, Andreas, 55131 Mainz, DE; VON EYNATTEN, Maximilian, 55216 Ingelheim Am Rhein, DE; JOHANSEN, Odd-Erik, 1363 Hoevik, NO; KIM, Gabriel Woojai, 55216 Ingelheim Am Rhein, DE; MAYOUX, Eric Williams, 55216 Ingelheim Am Rhein, DE; MUENZEL, Thomas, 55131 Mainz, DE; PERKINS, Bruce A., Burlington, Ontario L7L 5H4, CA; SALSALI, Afshin, Ridgefield, Connecticut 06877-0368, US; SOLEYMANLOU, Nima, Burlington, Ontario L7L 5H4, CA; WOERLE, Hans-Juergen, 55216 Ingelheim Am Rhein, DE |
| Address for service | | Boehringer Ingelheim International GmbH, 55218 Ingelheim, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361808807 P Apr 5, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361835811 P Jun 17, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| CA 2812016 Apr 10, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201461942301 P Feb 20, 2014
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361823041 P May 14, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361835809 P Jun 17, 2013
|
| Due date | FT FG | Apr 30, 2025 Annual fee for the 12th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002981255 Searchable text:
EP000002981255 Original document:
EP000002981255B1 Searchable text:
EP000002981255B1 Original document:
WO002014161918 Searchable text:
WO002014161918 |
43 | Date of first publication | EVT | Oct 9, 2014 |
| Date of the first transfer into DPMAregister | EREGT | Mar 25, 2016 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 6, 2025 (Show all update days)(Hide all update days)- Feb 6, 2025
- St.36: changed (technical change)
- Aug 8, 2024
- St.36: changed (technical change)
- Jul 11, 2024; Apr 27, 2024; Dec 21, 2023; May 25, 2023; May 4, 2023; May 3, 2023; Sep 29, 2022; Aug 25, 2022; Jan 6, 2022; May 18, 2017
- Historical data not available for this/these date(s)
- Mar 25, 2016
- Date of the first transfer into DPMAregister
|